Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
PharmaCyte Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 10
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Nuvilex Acquires Rights To Live-Cell Encapsulation Technology For Diabetes From SG Austria 12
Partnerships 13
PharmaCyte Biotech Partners with Translational Drug Development and Clinical Network Services 13
PharmaCyte Biotech Enters into Co-Development Agreement with University of Technology Sydney 14
Licensing Agreements 15
PharmaCyte Biotech Enters into Licensing Agreement with Austrianova Singapore for Cannabis Therapies 15
PharmaCyte Biotech Enters into Licensing Agreement with Austrianova Singapore 16
Nuvilex Enters into Licensing Agreement with University of Technology Sydney 17
Equity Offering 18
PharmaCyte Biotech to Raise up to USD25 Million in Public Offering of Shares 18
PharmaCyte Biotech Raises USD1 Million in Private Placement of shares 19
Nuvilex to Raise up to USD50 Million in Public Offering of Shares 20
Nuvilex Completes First Tranche Of Private Placement Of Shares For US$2 Million 21
Nuvilex Competes Private Placement Of Securities For US$1.5 Million 22
Acquisition 23
Nuvilex Acquires 14.5% Stake In SGAustria, Life Science Company 23
Nuvilex Acquires Bio Blue Bird For US$1.5 Million 24
PharmaCyte Biotech Inc – Key Competitors 25
PharmaCyte Biotech Inc – Key Employees 26
PharmaCyte Biotech Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Corporate Communications 28
Oct 10, 2017: PharmaCyte Biotech Appoints Dr. Raymond Tong to Board of Directors 28
Jul 26, 2017: PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer 29
Jul 10, 2017: PharmaCyte Biotech Appoints Dr. Michael M. Abecassis to Board of Directors 31
May 02, 2017: PharmaCyte Biotech Appoints Thomas Yuen to Board of Directors 32
Apr 03, 2017: PharmaCyte Biotech Appoints Dr. Mark Rabe Director of Cannabis Program Development 33
Legal and Regulatory 34
Nov 16, 2017: British Columbia Securities Commission Revokes Cease Trade Order on PharmaCyte Biotech Securities 34
Government and Public Interest 36
Feb 23, 2017: First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals 36
Product News 37
Dec 05, 2017: PharmaCyte Biotech Announces Production of Master Cell Bank 37
Oct 17, 2017: PharmaCyte Biotech Research Identifies Enzyme Activity for Cannabinoid-Based Therapy to Fight Cancer 38
04/18/2017: PharmaCyte Biotech Discusses Future of Cannabis Research Program, Competitors and More with Program’s Director 39
04/10/2017: PharmaCyte Biotech’s Cannabis Research Program Sees Significant Progress in University of Northern Colorado Presentations 41
Feb 13, 2017: PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal Trial Opportunity 43
01/24/2017: PharmaCyte Going Head to Head with Eli Lillys Pancreatic Cancer Drug in New Clinical Trial 45
Jan 10, 2018: PharmaCyte Announces Completion of Master Cell Bank 47
Product Approvals 48
Feb 13, 2017: PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal Trial Opportunity 48
Jan 30, 2017: PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA 50
Jan 04, 2017: PharmaCyte Biotech Announces Pre-IND Meeting Date with FDA 51
Clinical Trials 52
Feb 21, 2017: PharmaCyte Biotech Discusses Patient Enrollment and TD2s Role in Upcoming Clinical Trial 52
Other Significant Developments 54
Feb 06, 2018: PharmaCyte Announces Completion of Preparatory Work and Commencement of Testing by Eurofins of Cells from Its Master Cell Bank 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PharmaCyte Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 9
PharmaCyte Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 10
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Nuvilex Acquires Rights To Live-Cell Encapsulation Technology For Diabetes From SG Austria 12
PharmaCyte Biotech Partners with Translational Drug Development and Clinical Network Services 13
PharmaCyte Biotech Enters into Co-Development Agreement with University of Technology Sydney 14
PharmaCyte Biotech Enters into Licensing Agreement with Austrianova Singapore for Cannabis Therapies 15
PharmaCyte Biotech Enters into Licensing Agreement with Austrianova Singapore 16
Nuvilex Enters into Licensing Agreement with University of Technology Sydney 17
PharmaCyte Biotech to Raise up to USD25 Million in Public Offering of Shares 18
PharmaCyte Biotech Raises USD1 Million in Private Placement of shares 19
Nuvilex to Raise up to USD50 Million in Public Offering of Shares 20
Nuvilex Completes First Tranche Of Private Placement Of Shares For US$2 Million 21
Nuvilex Competes Private Placement Of Securities For US$1.5 Million 22
Nuvilex Acquires 14.5% Stake In SGAustria, Life Science Company 23
Nuvilex Acquires Bio Blue Bird For US$1.5 Million 24
PharmaCyte Biotech Inc, Key Competitors 25
PharmaCyte Biotech Inc, Key Employees 26
PharmaCyte Biotech Inc, Subsidiaries 27
List of Figures
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
PharmaCyte Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
PharmaCyte Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 10